Priority Date: 21.02.12 (IN 2012MUM461)

ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE

  • Application ID: EP13704974
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorney

Employment test 11 - 50 employees
Company dna abg patentes sl
operating since 2003
1101.95
Headquarter in Madrid and 1 office
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). ABG Patentes SL is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 21.02.2012 - Priority Date (IN 2012MUM461)
  • 29.08.2013 - Publication A1 (WO2013124340)
  • 31.12.2014 - Publication A1 (EP2817000)